Viewing Study NCT00398229



Ignite Creation Date: 2024-05-05 @ 5:09 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00398229
Status: COMPLETED
Last Update Posted: 2009-01-01
First Post: 2006-11-09

Brief Title: hCG Supplementation in Frozen-Thawed Embryo Transfer Cycle
Sponsor: Hadassah Medical Organization
Organization: Hadassah Medical Organization

Study Overview

Official Title: The Benefit of Human Chorionic Gonadotropin hCG Supplementation Throughout the Secretory Phase of Frozen-Thawed Embryo Transfer Cycles
Status: COMPLETED
Status Verified Date: 2007-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The implantation rate after frozen-thawed embryo transfer cycles depends mostly on the receptivity of the endometrium and the embryo qualityThe effects of human chorionic gonadotropins hCG on the endometrium have been investigated for several years hCG was shown to up-regulate gene expression during the differentiation of human endometrial stromal cells into decidua The aim of our study was to assess the benefit of hCG supplementation throughout the secretory phase of artificial frozen-thawed embryo transfer cycles
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None